The new frontier: assessing efficacy and safety of CGTs using biomarkers
Update: 2024-09-27
Description
In the sixth episode of The new frontier podcast, we're joined by Catherine Vrentas, Life Sciences Lead at Booz Allen Hamilton (VA, USA). Cathy explains how biomarkers can be used to predict the therapeutic outcome and efficacy of CGTs and the biomarkers in particular that have shown strong predictive value. We delve into the common challenges of working with biomarkers in CGTs and how biomarker kits can be adapted for CGT work.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
